[Announcing cancer diagnosis: which communication difficulties from professional and from patient's side? Which possible improvements?].

Abstract:

:Announcing a cancer diagnosis, but also a relapse, a progression of the disease, or transition towards palliative care constitute particularly difficult communication issues for the patient as well as for the clinician, during the trajectory of care. The objectives of this article is to present the clinical stakes of these situations, to describe the difficulties in establishing a "good" doctor-patient relationship, to provide indications or even recommendations on the ways to facilitate communication in order to ensure a optimal quality of care, responding to patients needs and ensuring the continuity of the care. Communication relates to the relation and the information delivered between patient and clinician, but also within the medical team. We analyse here the essential components of the process of "diagnosis consultation", organised in many cancer centers around France. In addition, we present the diverse training programs on communication skills that have been developed and tested in the setting of oncology, open to all professionals. Its specificity relates to its multidisciplinary character; the quality of the doctor-patient communication also depends on the quality of the communication and coordination within the team. This dimension is the subject of specific attention carried by supportive care teams.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Dolbeault S,Brédart A

doi

10.1684/bdc.2010.1197

subject

Has Abstract

pub_date

2010-10-01 00:00:00

pages

1183-94

issue

10

eissn

0007-4551

issn

1769-6917

pii

S0007-4551(15)30772-4

journal_volume

97

pub_type

杂志文章
  • [Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].

    abstract::From July 1987 to July 1988, 35 patients with non small cell lung cancer, stage IV, were included in a phase II trial (GLOT NPC 87/01). The treatment was as follows: cisplatin 50 mg/m2 day 1, vindesin 3 mg/m2 day 1, mitomycin 6 mg/m2 day 2, and bleomycin 15 mg/day, day 1 + 2 by continuous infusion. The evaluation for ...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Souquet PJ,Fournel P,Jorda M,Laennec E,Piperno D,Trillet V,Rebattu P,Bernard JP

    更新日期:1993-01-01 00:00:00

  • [Tumor-stroma interactions].

    abstract::It is widely accepted that the development of carcinoma is not only due to somatic mutations in epithelial cells but also is influenced by the tumor microenvironment ie the stroma. The different stroma components produced growth factors, cytokines, the extra cellular matrix and also participated to the recruitment of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0560

    authors: Billottet C,Jouanneau J

    更新日期:2008-01-01 00:00:00

  • [Decision making process in oncology: rationale and delineation of a composite index of relative antitumoral efficacy (In-RATE)].

    abstract::Over the last decade, the development of new therapeutic options has made more patients benefit from antitumoral strategies including several lines of chemotherapy, the aim of which is a long-term control of the disease progression. In such a context of "chronic" management, the choice of tumor response as a single pa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2008.0738

    authors: Marty M,Blay JY,Trédaniel J,Koscielny S,Hagège C,Asselain B,Goldwasser F,Misset JL

    更新日期:2008-11-01 00:00:00

  • [Adjuvant treatment of colon cancer MOSAIC study's main results].

    abstract::Oxaliplatin in combination with 5-fluorouracil/leucovorin (LV5FU) improves the response rate and survival of patients with metastatic colorectal cancer. The objective of the Mosaic study was to evaluate the efficacy of this association in the adjuvant treatment of stage II and III colon cancer. This international stud...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: André T,Tournigand C,Achille E,Tubiana-Mathieu N,Lledo G,Raoul Y,Carola E,Flesch M,Muron T,Boutan-Laroze A,Guérin Meyer V,Boaziz C,Maigre M,Ganem G,Mousseau M,Mounedji-Boudiaf L,de Gramont A

    更新日期:2006-02-01 00:00:00

  • [Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].

    abstract:CONTEXT:The "Standards, Options and Recommendations" (SOR) collaborative project was initiated in 1993 by the Federation of the French Cancer Centres (FNCLCC), with the 20 French Regional Cancer Centres, several French public university and general hospitals, as well as private clinics and medical specialty societies. ...

    journal_title:Bulletin du cancer

    pub_type: 指南,杂志文章,实务指引

    doi:

    authors: Denoux Y,Blanc-Vincent MP,Simony-Lafontaine Jl,Verriele-Beurrier V,Briffod M,Voigt JJ

    更新日期:2002-04-01 00:00:00

  • [Fertility and the progeny of children surviving cancer treatment (author's transl)].

    abstract::Little is known about the late effects of damage to the gonads in children treated for cancer. This investigation requires a prolonged surveillance. Radiotherapy sterilizes the ovaries above a dose of about 500 rads in an adult. Therefore, to protect at least one ovary in partial irradiation of a child's abdomen in ma...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Flamant F,Schweisguth O

    更新日期:1979-01-01 00:00:00

  • [Prospective evaluation of pain induced by the transport of patients in the hospital: risk factors and proposal for improvement].

    abstract::Cancer patients are often moved inside the hospital to different examination clinics, such as radiology, CT scan, MRI... and to treatment clinics, such as radiotherapy. These transports induce important pain phenomena, not really recognized by professional teams. As these kinds of pains are expected and can be prevent...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2008.0638

    authors: Nebbak JM,Mathivon D,Di Palma M

    更新日期:2008-05-01 00:00:00

  • [Renal failure after allogeneic hematopoietic stem cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].

    abstract::Acute and chronic renal failures are very common after allogeneic HSCT. These complications have a real impact on mortality and morbidity of transplant recipients. Within the framework of the ninth workshops of practice harmonization of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2019.05.002

    authors: Detrait M,de Berranger E,Dulery R,Ménard AL,Thépot S,Toprak SK,Turlure P,Yakoub-Agha I,Guillaume T

    更新日期:2020-01-01 00:00:00

  • [Stereotactic radiosurgery and radiotherapy for brain metastases].

    abstract::Brain metastases management is still controversial even though many trials are trying to define the respective roles of neurosurgery, whole-brain radiotherapy, single-dose stereotactic radiotherapy and fractionated stereotactic radiotherapy. In this article, we review data from trials that examine the role of radiosur...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1683

    authors: Tanguy R,Métellus P,Mornex F,Mazeron JJ

    更新日期:2013-01-01 00:00:00

  • [Metastatic breast cancer: controlled trial of chemotherapy with and without hormones].

    abstract::Two hundred and twenty-three patients with disseminated breast cancer entered in a randomized trial: Group I: 130 patients were given a monthly 5 day- course of a cytotoxic chemotherapy protocol including Adriamycine, Vincristine, Cyclophosphamide, 5 Fluoro-uracile (A.V.L.F.); Group II: 93 patients were given alternat...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Jouve M,Palangie T,Garcia-Giralt E,Bretaudeau B,Magdelenat H,Asselain B,Pouillart P

    更新日期:1984-01-01 00:00:00

  • [Frequency of cancer at older ages].

    abstract::The dependency between the risk of death and age is analysed, and the contribution of cancer to the overall risk of death is evaluated as a function of age. The frequency of the different cancer sites is described in different age groups. Lastly cancer mortality trends are presented by age. The risk of death from canc...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2007.0531

    authors: Hill C,Doyon F

    更新日期:2008-05-28 00:00:00

  • [Prognostical factors of breast neoplasms without metastasis. Synthesis by a multifactoral analysis].

    abstract::Multifactorial analysis by dichotomous split was applied to a consecutive series of 541 female breast cancer patients without detectable metastasis at onset of treatment. These patients were entirely treated in the same institution (Fondation Bergonié), in the years 1960-1974. This multifactorial analysis sets a hiera...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lagarde C,Avril A,Dilhuydy MH,Durand M,Hugues A,Imbert J,Palangie F,Richaud P

    更新日期:1977-01-01 00:00:00

  • [New insight into MyoD regulation: involvement in rhabdomyosarcoma pathway?].

    abstract::The transcription factor MyoD, member of the myogenic regulators family, induces differentiation in precursor cells by its ability to arrest cell proliferation and to activate muscle specific genes. MyoD plays a key role in the antagonism between proliferation and differentiation. The withdrawal from the cell cycle an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Tintignac LA,Leibovitch MP,Leibovitch SA

    更新日期:2001-06-01 00:00:00

  • [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].

    abstract::For most diseases, one observes great variability in clinical course and response to therapy which should be taken into account in the design and the analysis of clinical trials. Eligibility criteria and stratified randomization use prognostic knowledge. A suitable analysis of randomized studies includes: (1) checking...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Byar D,Chastang C

    更新日期:1987-01-01 00:00:00

  • On the value of response criteria in therapeutic research.

    abstract::Primary chemotherapy is the use of anticancer drugs as the first treatment in patients with localized tumor presentations for which there is an alternative but less than satisfactory treatment. Its most important feature is the preservation of the primary tumor mass as a biologic marker of response, and in this sense ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Devita VT Jr

    更新日期:1988-01-01 00:00:00

  • [Circulating tumor cells and advanced prostate cancer].

    abstract::Despite development and widespread of PSA, current tools evaluating prostate cancer still give inconsistent or insufficiently relevant results. As encouraging data raised from circulating tumor cells detection in colon or breast cancer, they were evaluated as a surrogate prostate cancer biomarker. Tumor cells need to ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1565

    authors: Murez T,Droupy S,Rebillard X,Alix-Panabieres C

    更新日期:2012-07-01 00:00:00

  • [Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to express a chimeric antigen receptor targeting an antigen expressed on tumor cells such as CD19. CAR T-cells represent a new class of medicinal products, and belong to the broad category of Advanced Therapy Medicinal Products ...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2017.10.017

    authors: Yakoub-Agha I,Ferrand C,Chalandon Y,Ballot C,Castilla Llorente C,Deschamps M,Gauthier J,Labalette M,Larghero J,Maheux C,Moreau AS,Varlet P,Pétillon MO,Pinturaud M,Rubio MT,Chabannon C

    更新日期:2017-12-01 00:00:00

  • [Radioimmunotargeting: diagnosis and therapeutic use].

    abstract::Monoclonal antibodies labeled with a radionuclide make feasible the in vivo radioimmunotargeting of tumor cells. This targeting could be performed for diagnosis, using gamma emitters, or for therapeutic purpose when antibodies are labeled with beta- and in the future alpha-emitters. Diagnosis applications (tumor detec...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Vuillez JP

    更新日期:2000-11-01 00:00:00

  • [Value of detection of hormone receptors by biochemical and immunochemical methods in therapeutic decision for breast cancer].

    abstract::Receptor assays for both ER and PR in breast cancer specimens is used either to choose adjuvant therapy during the first treatment, or to choose hormone therapy for metastatic patients, or for the diagnosis of tumors. Whereas biochemical methods, either by radioligand or by monoclonal antibodies, have progressed over ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Goussard J

    更新日期:1996-12-01 00:00:00

  • [Small cell carcinoma. Incidence, histopathology and anatomical features. Analysis of 465 autopsied bronchopulmonary carcinomas (author's transl)].

    abstract::465 patients with broncho-pulmonary malignant tumors have been autopsied. Small cell carcinoma was diagnosed in 22.5 per cent of these patients. The histo-cytological variants of these tumors (lymphocytoid, polygonal, fusiform and polymorphic) had the same general characteristics (age, sex, survival) and a similar cli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Chomette G,Auriol M,Tranbaloc P,Esperandieu O,Guettier C

    更新日期:1982-01-01 00:00:00

  • [Suicidal crisis in oncology: assessment and care].

    abstract::Patients with advanced cancer often experience with physical impairment and loss of autonomy sometimes preceding inexorable death. It is that can emerge Suicidal ideation occasionally associated with suicidal attempt can arise in this particular context but also following the initial diagnostic talk and during all the...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lefetz C,Reich M

    更新日期:2006-07-01 00:00:00

  • [Role of interleukin 6 in hepatocellular carcinoma].

    abstract::Interleukin 6 (IL-6) is a pleiotropic cytokine which possesses a broad spectrum of action in diverse pathological conditions. It is mainly produced and metabolised in the liver where it carries out one of its best known actions in the mediation of the acute phase response. We studied its behaviour in hepatocellular ca...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Malaguarnera M,Di Fazio I,Laurino A,Romeo MA,Giugno I,Trovato BA

    更新日期:1996-05-01 00:00:00

  • [What do we know about ATM protein expression in breast tissue?].

    abstract::The great majority of breast cancer cases are not associated with a mutated gene of high penetrance such as BRCA1, BRCA2 and TP53. Genes of low penetrance, frequently mutated in the general population, might play an important role in breast cancer development. The ATM gene, which encodes the ATM protein, mutated in th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Angèle S,Tanière P,Hall J

    更新日期:2001-07-01 00:00:00

  • [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].

    abstract::In response to the evolution of the information-seeking behaviour of patients and concerns from health professionals regarding cancer patient information, the French National Federation of Comprehensive Cancer Centres (FNCLCC) introduced, in 1998, an information and education program dedicated to patients and relative...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,病人教育讲义

    doi:

    authors: Bourguet P,Brusco S,Corone C,Devillers A,Foehrenbach H,Lumbroso JD,Maszelin P,Montravers F,Moretti JL,Rain JD,Talbot JN,Carretier J,Leichtnam-Dugarin L,Delavigne V,Philip T,Fervers B,Fédération nationale des centres de lu

    更新日期:2005-07-01 00:00:00

  • [Metastatic screening before adjuvant chemotherapy in breast cancer].

    abstract:INTRODUCTION:Systematic metastasis staging in early breast cancer is no longer recommended. However, it is still performed before adjuvant chemotherapy. MATERIALS AND METHODS:We assessed metastasis screening of asymptomatic women with a local breast cancer without lymph node involvement when adjuvant chemotherapy was ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.02.018

    authors: Thonnon C,Faure C,Chopin N,Beurrier F,Ho Quoc C,Tredan O,Carrabin N

    更新日期:2015-05-01 00:00:00

  • [Prostatic carcinoma: histoprognosis, prognostic value of Gleason's index].

    abstract::This paper recalls the definition of the Gleason index and describes the five architectural types that enable a calculation of the index. The conditions of the practical application of the index are defined, with a discussion of reproducibility of results based on current literature and the author's experience. The in...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Saint-André JP,Rousselet MC,Six P,Bertrand G,Soret JY

    更新日期:1985-01-01 00:00:00

  • [CD44 expression: a new prognostic factor in neuroblastoma].

    abstract::CD44 gene products are potential markers of aggressiveness in different tumor models, a result which prompted us to study clinical neuroblastoma (NB) specimens. CD44 expression was determined by immunostaining of 52 NB with a monoclonal antibody (J173) directed against an epitope common to all CD44 isoforms. All tumor...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Combaret V,Lasset C,Bouvier R,Frappaz D,Thiesse P,Rebillard AC,Philip T,Favrot MC

    更新日期:1995-01-01 00:00:00

  • [Socio-anthropological perspective of the under nutrition care of cancer patients].

    abstract::The diet of the cancer patient is a major focus of prevention and treatment strategy of the recent plans that fight against cancer. It is sometimes reduced to a rapid series of more or less general advice, often interfered by other sources of information, more or less conventional. In this pathological situation where...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1905

    authors: Fontas M,Poulain JP,Souquet PJ,Laville M,Giboreau A,Bensafi M,Mazières J

    更新日期:2014-03-01 00:00:00

  • Is the proportion of hypoxic cells in a solid tumour dependent on the host (mouse or rat)?

    abstract::Hypoxic cell fraction was measured in a human tumour xenografted on two different animal species: mouse and rat. These results suggest that, while the Na11 tumour response to radiation depends on the host (nude mouse, nude rat), the proportion of hypoxic cells tested with the growth delay assay is independent of the h...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Guichard M,Chavaudra N,Malaise EP

    更新日期:1989-01-01 00:00:00

  • [PNET/Ewing tumours: current treatments and future perspectives].

    abstract::Ewing tumours are characterised as tumours consisting of small, blue, round malignant cells that may exhibit varying degrees of neural differentiation. Most of them arise in bony sites, and they represent the second commonest primary osseous malignancy in and adolescence and young adults. During the past 30 years, che...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1120

    authors: Marec-Bérard P,Chotel F,Claude L

    更新日期:2010-06-01 00:00:00